These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 27445292

  • 1. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    Lin C, Bradshaw T, Perk T, Harmon S, Eickhoff J, Jallow N, Choyke PL, Dahut WL, Larson S, Humm JL, Perlman S, Apolo AB, Morris MJ, Liu G, Jeraj R.
    J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
    [Abstract] [Full Text] [Related]

  • 2. Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.
    Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, Davis ID, Ackermann U, Pathmaraj K, Schuit RC, Windhorst AD, Chua S, Weber WA, Larson SM, Scher HI, Lammertsma AA, Hoekstra OS, Morris MJ.
    J Nucl Med; 2018 Oct; 59(10):1516-1523. PubMed ID: 29626121
    [Abstract] [Full Text] [Related]

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Oct; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 4. Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients.
    Letellier A, Johnson AC, Kit NH, Savigny JF, Batalla A, Parienti JJ, Aide N.
    Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
    [Abstract] [Full Text] [Related]

  • 5. Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone.
    Harmon SA, Perk T, Lin C, Eickhoff J, Choyke PL, Dahut WL, Apolo AB, Humm JL, Larson SM, Morris MJ, Liu G, Jeraj R.
    J Clin Oncol; 2017 Aug 20; 35(24):2829-2837. PubMed ID: 28654366
    [Abstract] [Full Text] [Related]

  • 6. The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.
    Donners R, Tunariu N, Tovey H, Hall E, Chua S, Cook G, Du Y, Blackledge MD, Parker CC, Koh DM.
    Eur Radiol; 2024 Feb 20; 34(2):1146-1154. PubMed ID: 37615760
    [Abstract] [Full Text] [Related]

  • 7. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
    Oprea-Lager DE, Kramer G, van de Ven PM, van den Eertwegh AJ, van Moorselaar RJ, Schober P, Hoekstra OS, Lammertsma AA, Boellaard R.
    J Nucl Med; 2016 May 20; 57(5):721-7. PubMed ID: 26697964
    [Abstract] [Full Text] [Related]

  • 8. Response-to-repeatability of quantitative imaging features for longitudinal response assessment.
    Lin C, Harmon S, Bradshaw T, Eickhoff J, Perlman S, Liu G, Jeraj R.
    Phys Med Biol; 2019 Jan 18; 64(2):025019. PubMed ID: 30566922
    [Abstract] [Full Text] [Related]

  • 9. Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate Cancer.
    Roth AR, Harmon SA, Perk TG, Eickhoff J, Choyke PL, Kurdziel KA, Dahut WL, Apolo AB, Morris MJ, Perlman SB, Liu G, Jeraj R.
    Clin Genitourin Cancer; 2019 Aug 18; 17(4):306-314. PubMed ID: 31221545
    [Abstract] [Full Text] [Related]

  • 10. Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.
    Uprimny C, Svirydenka A, Fritz J, Kroiss AS, Nilica B, Decristoforo C, Haubner R, von Guggenberg E, Buxbaum S, Horninger W, Virgolini IJ.
    Eur J Nucl Med Mol Imaging; 2018 Oct 18; 45(11):1873-1883. PubMed ID: 29766246
    [Abstract] [Full Text] [Related]

  • 11. Automated classification of benign and malignant lesions in 18F-NaF PET/CT images using machine learning.
    Perk T, Bradshaw T, Chen S, Im HJ, Cho S, Perlman S, Liu G, Jeraj R.
    Phys Med Biol; 2018 Nov 20; 63(22):225019. PubMed ID: 30457118
    [Abstract] [Full Text] [Related]

  • 12. Observer Agreement and Accuracy of 18F-Sodium Fluoride PET/CT in the Diagnosis of Bone Metastases in Prostate Cancer.
    Zacho HD, Fonager RF, Nielsen JB, Haarmark C, Hendel HW, Johansen MB, Mortensen JC, Petersen LJ.
    J Nucl Med; 2020 Mar 20; 61(3):344-349. PubMed ID: 31481577
    [Abstract] [Full Text] [Related]

  • 13. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    Kramer GM, Frings V, Hoetjes N, Hoekstra OS, Smit EF, de Langen AJ, Boellaard R.
    J Nucl Med; 2016 Sep 20; 57(9):1343-9. PubMed ID: 27103020
    [Abstract] [Full Text] [Related]

  • 14. Quantitative Test-Retest Measurement of 68Ga-PSMA-HBED-CC in Tumor and Normal Tissue.
    Pollard JH, Raman C, Zakharia Y, Tracy CR, Nepple KG, Ginader T, Breheny P, Sunderland JJ.
    J Nucl Med; 2020 Aug 20; 61(8):1145-1152. PubMed ID: 31806776
    [Abstract] [Full Text] [Related]

  • 15. Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [18F]NaF PET/MR.
    Schramm G, Maus J, Hofheinz F, Petr J, Lougovski A, Beuthien-Baumann B, Oehme L, Platzek I, van den Hoff J.
    Med Phys; 2015 Nov 20; 42(11):6468-76. PubMed ID: 26520736
    [Abstract] [Full Text] [Related]

  • 16. Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer.
    Weisman AJ, Harmon SA, Perk TG, Eickhoff J, Choyke PL, Kurdziel KA, Dahut WL, Humm JL, Apolo AB, Larson SM, Morris MJ, Perlman SB, Liu G, Jeraj R.
    Prostate Cancer Prostatic Dis; 2019 May 20; 22(2):324-330. PubMed ID: 30413807
    [Abstract] [Full Text] [Related]

  • 17. Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide.
    Kyriakopoulos CE, Heath EI, Ferrari A, Sperger JM, Singh A, Perlman SB, Roth AR, Perk TG, Modelska K, Porcari A, Duggan W, Lang JM, Jeraj R, Liu G.
    J Clin Oncol; 2020 Nov 01; 38(31):3662-3671. PubMed ID: 32897830
    [Abstract] [Full Text] [Related]

  • 18. Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative method.
    Lapa P, Marques M, Costa G, Iagaru A, Pedroso de Lima J.
    Nucl Med Commun; 2017 Apr 01; 38(4):325-332. PubMed ID: 28230714
    [Abstract] [Full Text] [Related]

  • 19. 18 F-NaF PET/CT IMAGING IN FIBROUS DYSPLASIA OF BONE.
    Papadakis GZ, Manikis GC, Karantanas AH, Florenzano P, Bagci U, Marias K, Collins MT, Boyce AM.
    J Bone Miner Res; 2019 Sep 01; 34(9):1619-1631. PubMed ID: 31116487
    [Abstract] [Full Text] [Related]

  • 20. Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.
    Rohren EM, Etchebehere EC, Araujo JC, Hobbs BP, Swanston NM, Everding M, Moody T, Macapinlac HA.
    J Nucl Med; 2015 Oct 01; 56(10):1507-12. PubMed ID: 26135112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.